1Cassidy J, Misset JL. Oxaliplatin- related side effects: characteristics and management. Semin Oncol, 2002, 29(5 Suppl 15): 11-20.
2Cavaletti G, Tredici G, Petruccioli MG, et al. Effects of different schedules of oxaliplatin treatment on the peripheral nervous system of the rat. Eur J Cancer, 2001,37(18): 2457-2463.
3Cats A. New developments in systemic chemotherapy in advanced colorectal cancer. Scand J Gastroenterol Suppl, 2003,38 (239): 78-86.
4Adelsberger H, Quasthoff S, Grosskreutz J, et al. The chemotherapeutic oxaliplatin alters voltage-gated Na(+) channel kinetics on rat sensory neurons. Eur J Pharmacol, 2000, 406(1): 25-32.
5McKeage MJ, Hsu T, Screnci D, et al. Nucleolar damage correlates with neurotoxicity induced by different platinum drugs. Br J Cancer,2001, 85(8): 1219-1225.
6Lehky TJ, Leonard GD, Wilson RH, et al. Oxaliplatin-induced neurotoxicity: acute hyperexcitability and chronic neuropathy. Muscle Nerve, 2004, 29(3): 387-392.
7Wilson RH, Lehky T, Thomas RR, et al. Acute oxaliplatin-induced peripheral nerve hyperexcitability. J Clin Oncol, 2002, 20 (7):1767-1774.
8Screnci D, McKeage M J, Galettis P, et al. Relationships between hydrophobicity, reactivity, accumulation and peripheral nerve toxicity of a series of platinum drugs. Br J Cancer, 2000, 82(4): 966-972.
9Boyle FM, Beatson C, Monk R, et al. The experimental neuroprotectant leukaemia inhibitory factor (LIF) does not compromise antitumour activity of paclitaxel, cisplatin and carboplatin. Cancer Chemother Pharmacol, 2001,48(6): 429-434.
10Cavaletti G, Petruccioli MG, Marmiroli P, et al. Circulating nerve growth factor level changes during oxaliplatin treatment-induced neurotoxicity in the rat. Anticancer Res, 2002, 22(6C): 4199-4204.
